171 results on '"Breathnach O"'
Search Results
2. The role of infiltrating lymphocytes in the neo-adjuvant treatment of women with HER2-positive breast cancer
3. Trauma assessment clinic: Virtually a safe and smarter way of managing trauma care in Ireland
4. The impact of outpatient systemic anti-cancer treatment on patient costs and work practices
5. Emergency aeromedical services in Ireland: a retrospective study for “MEDEVAC112”
6. BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitors
7. A Pilot Study to Investigate the Utility of Exhaled Breath Condensate as a Liquid Biopsy in the Detection of Spatial Genomic Heterogeneity in Patients with Early-Stage Non-Small Cell Lung Cancer
8. Chemotherapy induced peripheral neuropathy: the modified total neuropathy score in clinical practice
9. The effect of inclement weather on ankle fracture management in an Irish trauma unit
10. P59.23 Biomarker Testing for Non-Small Cell Lung Cancer at a Tertiary Referral Hospital in Ireland: Challenges and Opportunities
11. Electronic clinical decision support systems attitudes and barriers to use in the oncology setting
12. Patterns of participation of patients in cancer clinical trials in Ireland
13. Practical problems and resource implications with the use of warfarin for venous thromboembolism in patients with cancer
14. The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer
15. Advanced Merkel cell cancer and the elderly
16. Electrochemotherapy — preclinical development and clinical utility
17. Challenging Problems in Advanced Malignancy: CASE 4. USE OF POSITRON EMISSION TOMOGRAPHY TO SOLVE A DIAGNOSTIC DILEMMA IN A PATIENT WITH NON-HODGKIN’S LYMPHOMA
18. Bone marrow micrometastases in oesophago-gastric cancer — Evidence for clearance in patients receiving neoadjuvant chemoradiotherapy
19. 1277P The role of palliative care in patients with glioblastoma multiforme: A single centre review
20. Bronchioloalveolar carcinoma of the lung: Recurrences and survival in patients with stage I disease
21. Taxane-resistant lymphoepithelial-like carcinoma: Excellent response to VIP chemotherapy
22. Abstract OT3-06-01: Phase Ib clinical trial of coPANlisib in combination with Trastuzumab emtansine (T-DM1) in pre-treated unresectable locally advanced or metastatic HER2-positive breAst cancer (BC) “PANTHERA”-CTRIAL-IE 17-13
23. Smoking patterns and attitudes to smoking cessation among patients actively receiving anti-cancer treatment
24. Cytomegalovirus pneumonia in a patient with breast cancer on chemotherapy: Case report and review of the literature
25. Abstract OT3-06-05: A phase Ib/II trial of coPANlisib in combination with tratuzumab in pretreated recurrent or metastatic HER2-positive breast cancer “PantHER”
26. Abstract P6-08-17: Pregnancy associated breast cancer: Evaluating maternal outcomes. A multicentre study
27. Virtual Fracture Clinic in a Paediatric Population – What is the Evidence?
28. Introducing a specialist drug kardex can significantly change prescribing practices for VTE in cancer patients
29. The pharmacokinetics of methotrexate with and without rituximab in the treatment of primary central nervous system lymphoma (PCNSL)
30. The impact of outpatient systemic anti-cancer treatment on patient costs and work practices
31. Abstract OT3-02-03: An observational study of dose dense chemotherapy with lipegfilgrastim support in early breast cancer
32. Emergency aeromedical services in Ireland: a retrospective study for “MEDEVAC112”
33. 1964 Pilot study of bevacizumab (Bev) in combination with docetaxel (T) and cyclophosphamide (C) as adjuvant treatment (AdjRx) for patients (pts) with early stage (ES) HER-2 normal breast cancer (BrCa) ICORG 08-10
34. Effect of Thyroid Transcription Factor-1 (TTF-1) on Outcome Following Chemotherapy for Advanced Pulmonary Adenocarcinoma
35. Assessment of older patients with cancer: Edmonton Frail Scale (EFS) as a predictor of adverse outcomes in older patients undergoing radiotherapy
36. 332P - The pharmacokinetics of methotrexate with and without rituximab in the treatment of primary central nervous system lymphoma (PCNSL)
37. Life-threatening gastrointestinal haemorrhage in Von Recklinghausen's disease.
38. The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer
39. Chemotherapy induced peripheral neuropathy: the modified total neuropathy score in clinical practice
40. Emergency Aeromedical Services in Ireland – A Single- Centre Study in 2014.
41. P2-18-04: Pilot Evaluation of Bevacizumab (Bev) in Combination with Docetaxel (T) and Cyclophosphamide (C) as Adjuvant Treatment (AdjRx) for Patients (pts) with Early Stage (ES) Breast Cancer (BrCa).
42. 8747 POSTER Single Agent Bevacizumab for Recurrent Malignant Glioma
43. Hemodynamic performance of NMES in the early post operative period following orthopaedic surgery
44. A review of adverse event reporting in Irish surgical specialties
45. Abstract P5-10-17: Bevacizumab (Bev) in Combination with Docetaxel (T) and Cyclophosphamide (C) as Adjuvant Treatment (AdjRx) for Patients (pts) with Early Stage (ES) Breast Cancer (BrCa) and Normal HER-2 Status. A Pilot Evaluation
46. Adjuvant chemotherapy for colorectal cancer in the over 75 age group: A 10-year experience.
47. EBV-positive B cell cerebral lymphoma 12 years after sex-mismatched kidney transplantation: post-transplant lymphoproliferative disorder or donor-derived lymphoma?
48. Primary central nervous system lymphoma: An Irish clinical experience
49. The frequency of febrile neutropenia in oncology patients receiving chemotherapy
50. Rates of psychiatric illness in patients with cancer: An analysis of a psycho-oncology service
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.